Bristol-Myers Squibb Key Facts

The global business at a glance...

Chief Executive Officer (CEO):
Giovanni Caforio
Headquarters:
New York City
Website address:
www.bms.com
Stock exchange listing:
BMY (New York Stock Exchange)
Net sales:
$US 16.6 billion (2015)
R&D investment:
$US 4.04 billion (2015)
Key business:
Biopharmaceuticals

The Australian business at a glance...

Australian head office:
Level 2, 4 Nexus Court, Mulgrave, VIC 3170
Number of employees:
>300 (2016)
Australian product sales:
$226 million (2015)
Key Products:
BARACLUDE® (entecavir)
DAKLINZA® (daclatasvir)
ELIQUIS® (apixaban)
EVOTAZ® (atazanavir & cobicistat)
OPDIVO® (nivolumab)
ORENCIA® (abatacept)
REYATAZ® (atazanavir sulfate)
SPRYCEL® (dasatinib)
SUNVEPRA® (asunaprevir)
YERVOY™ (ipilimumab)